| Revista: | Quimica nova |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000198656 |
| ISSN: | 0100-4042 |
| Autors: | Lima, Lidia Moreira1 Fraga, Carlos Alberto Manssour Barreiro, Eliezer J |
| Institucions: | 1Universidade Federal do Rio de Janeiro, Instituto de Quimica, Rio de Janeiro. Brasil 2Universidade Federal do Rio de Janeiro, Faculdade de Farmacia, Rio de Janeiro. Brasil |
| Any: | 2001 |
| Període: | Sep-Oct |
| Volum: | 24 |
| Número: | 5 |
| Paginació: | 683-688 |
| País: | Brasil |
| Idioma: | Portugués |
| Tipo de documento: | Artículo |
| Enfoque: | Teórico, divulgación |
| Resumen en inglés | Thalidomide, first synthesized in 1953, was widely prescribed for morning sickness of pregnant women from 1957 to 1961, when it was found to be seriously teratogenic, having caused serious birth defect. Nowadays, a quarter of a century later, it appears that it may be a miracle drug for such diseases as leprosy, AIDS, cancer and tuberculosis |
| Disciplines | Química, Medicina |
| Paraules clau: | Química farmacéutica, Farmacología, Terapéutica y rehabilitación, Talidomida, SIDA, Lepra, Cáncer, Tuberculosis, Tratamiento |
| Keyword: | Chemistry, Medicine, Medicinal chemistry, Pharmacology, Therapeutics and rehabilitation, Thalidomide, AIDS, Cancer, Tuberculosis, Treatment, Leprosy |
| Text complet: | Texto completo (Ver HTML) |
